BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19046841)

  • 1. Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).
    Mabille M; Vanel D; Albiter M; Le Cesne A; Bonvalot S; Le Péchoux C; Terrier P; Shapeero LG; Dromain C
    Eur J Radiol; 2009 Feb; 69(2):204-8. PubMed ID: 19046841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.
    Vanel D; Albiter M; Shapeero L; Le Cesne A; Bonvalot S; Le Pechoux C; Terrier P; Petrow P; Caillet H; Dromain C
    Eur J Radiol; 2005 Apr; 54(1):118-23. PubMed ID: 15797301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib.
    Kim HC; Lee JM; Choi SH; Han H; Kim SS; Lee SH; Han JK; Choi BI
    Korean J Radiol; 2004; 5(3):157-63. PubMed ID: 15467412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
    Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
    Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.
    De Giorgi U; Aliberti C; Benea G; Conti M; Marangolo M
    Clin Cancer Res; 2005 Sep; 11(17):6171-6. PubMed ID: 16144917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
    Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
    J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases.
    Linton KM; Taylor MB; Radford JA
    Br J Radiol; 2006 Aug; 79(944):e40-4. PubMed ID: 16861316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A treatment using STI571 for jejunal gastrointestinal stromal tumor (GIST) accompanied with liver metastasis and peritoneal dissemination.
    Okamoto K; Muguruma N; Aoki R; Sato Y; Nakamoto J; Imoto Y; Okamura S; Ito S; Okitsu H; Sano T
    Intern Med; 2004 Dec; 43(12):1151-6. PubMed ID: 15645649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors.
    Desai J; Shankar S; Heinrich MC; Fletcher JA; Fletcher CD; Manola J; Morgan JA; Corless CL; George S; Tuncali K; Silverman SG; Van den Abbeele AD; van Sonnenberg E; Demetri GD
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5398-405. PubMed ID: 17875769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of surgical cytoreduction prior to imatinib therapy on the prognosis of patients with advanced GIST.
    An HJ; Ryu MH; Ryoo BY; Sohn BS; Kim KH; Oh ST; Yu CS; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2013 Dec; 20(13):4212-8. PubMed ID: 24052319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imatinib mesylate (glivec) as a treatment for gastrointestinal stromal tumor (GIST)--long term follow-up].
    Raccah E; Merimsky O; Kuten A; Apter S; Catane R
    Harefuah; 2007 May; 146(5):329-34, 408. PubMed ID: 17674545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.
    Bechtold RE; Chen MY; Stanton CA; Savage PD; Levine EA
    Abdom Imaging; 2003; 28(6):808-14. PubMed ID: 14753595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
    Shen L; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: comparison of RECIST, Choi and volumetric criteria.
    Schramm N; Englhart E; Schlemmer M; Hittinger M; Übleis C; Becker CR; Reiser MF; Berger F
    Eur J Radiol; 2013 Jun; 82(6):951-8. PubMed ID: 23518148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib.
    Schindler CG; Armbrust T; Gunawan B; Langer C; Füzesi L; Ramadori G
    Z Gastroenterol; 2005 Mar; 43(3):267-73. PubMed ID: 15765299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.
    Choi H; Charnsangavej C; de Castro Faria S; Tamm EP; Benjamin RS; Johnson MM; Macapinlac HA; Podoloff DA
    AJR Am J Roentgenol; 2004 Dec; 183(6):1619-28. PubMed ID: 15547201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
    Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
    Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy.
    Schlemmer M; Sourbron SP; Schinwald N; Nikolaou K; Becker CR; Reiser MF; Berger F
    Eur J Radiol; 2011 Feb; 77(2):312-8. PubMed ID: 19720488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
    Tirumani SH; Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH; Raut CP
    Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.